SCHEMBL1650408

SCHEMBL1650408

BrCCCBr.CN(C)CCCCCCN(C)C

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.69
TSHR P16473 1/20 0.69
DNM1 Q05193 3/20 0.55
SIGMAR1 Q99720 2/20 0.39
TDP1 Q9NUW8 1/20 0.35
CA12 O43570 1/20 0.35
CA2 P00918 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CA5B Q9Y2D0 1/20 0.35
HSD17B10 Q99714 1/20 0.34
KDM4A O75164 6/20 0.34
KDM4C Q9H3R0 6/20 0.34
KDM5A P29375 1/20 0.34
KDM7A Q6ZMT4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21246956 0.94 ALDH1A1 (0.69) ALDH1A1TSHRDNM1SIGMAR1TDP1
SCHEMBL14531094 0.94
SCHEMBL28285178 0.94 ALDH1A1 (0.69) ALDH1A1TSHRDNM1SIGMAR1TDP1
SCHEMBL11716299 0.94 ALDH1A1 (0.69) ALDH1A1TSHRDNM1SIGMAR1TDP1
Bromide SCHEMBL9491844 0.91 ALDH1A1 (0.65) ALDH1A1TSHRDNM1SIGMAR1TDP1
SCHEMBL9162423 0.90
SCHEMBL7895664 0.89 DNM1 (0.75) ALDH1A1TSHRDNM1SIGMAR1CA12
SCHEMBL8468925 0.89 DNM1 (0.75) ALDH1A1TSHRDNM1SIGMAR1CA12
SCHEMBL8467869 0.89 DNM1 (0.75) ALDH1A1TSHRDNM1SIGMAR1CA12
SCHEMBL7903605 0.89 DNM1 (0.75) ALDH1A1TSHRDNM1SIGMAR1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12514872-B2 Polycationic polymers for use in treating and detecting cancer DUKE UNIVERSITY (US) 2026-01-06 US claimed
EP-3810077-B1 HAIR DYEING COMPOSITION COMPRISING AN OXIDATION DYE, A SCLEROGLUCAN GUM, AN ALCANOLAMINE AND A MINERAL ALKALINE AGENT OREAL (FR) 2024-04-17 EP claimed
EP-2477641-B1 INHIBITION OF ENDOSOMAL TOLL-LIKE RECEPTOR ACTIVATION FOR TREATING THROMBOTIC DISORDERS UNIV DUKE (US) 2024-03-27 EP claimed
US-20230248805-A1 INHIBITION OF ENDOSOMAL TOLL-LIKE RECEPTOR ACTIVATION DUKE UNIVERSITY 2023-08-10 US claimed
EP-3810075-B1 DEVICE FOR DISPENSING A HAIR DYEING PRODUCT USING A DYE COMPOSITION AND AN OXIDIZING COMPOSITION COMPRISING A SCLEROGLUCAN GUM OREAL (FR) 2023-06-28 EP claimed
EP-3810076-B1 HAIR DYEING METHOD USING A DYE COMPOSITION AND AN OXIDIZING COMPOSITION, SAID COMPOSITIONS COMPRISING A SCLEROGLUCAN GUM OREAL (FR) 2022-08-03 EP claimed
EP-3810079-B1 HAIR DYEING COMPOSITION COMPRISING AN OXIDATION DYE, A SCLEROGLUCAN GUM AND AN ALKALINE AGENT SUCH AS AN AMINO ACID OREAL (FR) 2022-08-03 EP claimed
CN-104087594-B Obtain method and the application of sheep activin II receptors gene and its mutant 新疆维吾尔自治区畜牧科学院中国-澳大利亚绵羊育种研究中心 2017-08-08 CN claimed
CN-100389323-C Capillary electrophoresis enzyme micro reactor, its making method and purposes thereof SHANGHAI INST ORGANIC CHEM (CN) 2008-05-21 CN claimed
CN-1325904-C Photometry of paper pulp suspension liquid colloid dissolving electric charge UNIV SOUTH CHINA TECH (CN) 2007-07-11 CN claimed
CN-1737561-A Capillary electrophoresis enzyme microreactor, preparation method and purposes SHANGHAI INST ORGANIC CHEM (CN) 2006-02-22 CN claimed
CN-1410762-A Photometry of paper pulp suspension liquid colloid dissolving electric charge UNIV HUANAN SCIENCE & ENG (CN) 2003-04-16 CN claimed
US-20260137607-A1 COMPOSITION COMPRISING THE COMBINATION OF TWO PARTICULAR OXIDATION DYE PRECURSORS AND A FATTY ACID ESTER OF GLYCEROL LOREAL (FR) 2026-05-21 US disclosed
EP-4262716-B1 COMPOSITION COMPRISING A PARTICULAR OXIDATION DYE PRECURSOR AND A PARTICULAR CARBOXYLIC ACID OREAL (FR) 2026-05-06 EP disclosed
EP-4262720-B1 COMPOSITION COMPRISING TWO PARTICULAR OXIDATION DYE PRECURSORS, AND A PARTICULAR CARBOXYLIC ACID OREAL (FR) 2026-05-06 EP disclosed
EP-3893834-B1 STRAIGHTENING PROCESS FOR KERATIN FIBERS OREAL (FR) 2026-04-29 EP disclosed
CN-1177046-C Enhanced virus-mediated DNA transfer �Ƚ��о�������ѧ�� 2004-11-24 CN disclosed
CN-1410762-A Photometry of paper pulp suspension liquid colloid dissolving electric charge UNIV HUANAN SCIENCE & ENG (CN) 2003-04-16 CN disclosed
CN-1152875-A Enhanced virus-mediated DNA transfer INDIANA UNIVERSITY FOUNDATION (US) 1997-06-25 CN disclosed
US-4158649-A HYDROPHILIC RESIN, HEXADIMETHRINE BROMIDE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 1979-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260137607-A1 COMPOSITION COMPRISING THE COMBINATION OF TWO PARTICULAR OXIDATION DYE PRECURSORS AND A FATTY ACID ESTER OF GLYCEROL KRT18, FABP4, HSD17B4 ALDH1A1 441/4885TSHR 2670/4885DNM1 3974/4885
US-20230248805-A1 INHIBITION OF ENDOSOMAL TOLL-LIKE RECEPTOR ACTIVATION TLR3, TLR9, TLR1 ALDH1A1 4745/4885TSHR 2631/4885DNM1 873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.